Congratulations to Dr Mohamed Abdelghani who has been awarded the Clinical TMS Society President’s Award 2018 for his outstanding work on Transcranial Magnetic Stimulation.
Launched as a treatment at the Trust in September 2016, Transcranial Magnetic Stimulation (TMS) is used to treat individuals with drug-resistant depression.
The device uses a pulsating magnetic field to target specific sites in the brain, stimulating nerve cells in those areas, thereby easing symptoms of depression.
Dr Abdelghani, Consultant Psychiatrist, picked up his award at the sixth Clinical TMS Society Annual Meeting in New York in May.
The award, presented to him by the Society President, Dr Michelle Cochran (both pictured above), is given annually for celebration of ‘dedication, coordination, efforts and leadership to advance the ideals of the Clinical TMS Society’.
Dr Abdelghani led on the project to bring TMS to C&I and completed intensive training focused on TMS in Harvard and South Carolina in the United States of America.
He said of the award: “I felt humbled and honoured to it, especially as the society has among its ranks many of the pioneers in the field. It has made me feel even more motivated to continue to spread awareness of TMS as an effective and promising treatment for some mental disorders as well as making it more available to suitable patients.”
Angela McNab, Chief Executive, said: “This is fantastic news for both Dr Abdelghani and for the Trust.
“By bringing TMS to the Trust Mo has enabled our service users to have access to world class, innovative treatment. This award is well-earned recognition of his commitment and contribution to raising awareness around TMS.”